ID   NIH-3T3-V185
AC   CVCL_E9X9
SY   NIH 3T3-V185; NIH 3T3 V185; NIH3T3-V185; NIH MDR1-V185; NIH-MDR-V185; V185
RX   PubMed=1356986;
RX   PubMed=7866993;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1 (Note=With p.Val185).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=7866993;
RA   Cardarelli, Carol O.
RA   Aksentijevich, Ivan
RA   Pastan, Ira
RA   Gottesman, Michael Marc
RT   "Differential effects of P-glycoprotein inhibitors on NIH3T3 cells
RT   transfected with wild-type (G185) or mutant (V185) multidrug
RT   transporters.";
RL   Cancer Res. 55:1086-1091(1995).
//
RX   PubMed=1356986; DOI=10.1016/S0021-9258(19)36791-2;
RA   Bruggemann, Edward P.
RA   Currier, Stephen J.
RA   Gottesman, Michael Marc
RA   Pastan, Ira
RT   "Characterization of the azidopine and vinblastine binding site of
RT   P-glycoprotein.";
RL   J. Biol. Chem. 267:21020-21026(1992).
//